- Home
- / Parallax Health Sciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Parallax Health Sciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2022-07-19
Market Capitalization
$27.1 K
2022-07-19
Revenue
$128.6 K
FY, 2019
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 192.2K | 11.6M | 22.7M | 3.2M | 11.7K | 128.6K | |||
| Cost of goods sold | 90.1K | 9.9M | 19.2M | 3.2M | 20.3K | 16.8K | |||
| Gross profit | 102.2K | 1.7M | 3.6M | (31.1K) | (8.6K) | 111.8K | |||
| Gross profit margin, % | 53.1% | 14.7% | 15.7% | -1.0% | -73.3% | 86.9% | |||
| General and administrative expense | 2.0M | 482.6K | 473.4K | 858.7K | 1.9M | 4.9M | 6.4M | 6.6M | 6.5M |
| Operating expense total | 2.0M | 482.6K | 473.4K | 858.7K | 3.0M | 6.7M | 7.1M | 6.6M | 6.5M |
| Depreciation and amortization | 12.2K | (8.0K) | |||||||
| EBIT | (1.9M) | (482.6K) | (473.4K) | (858.7K) | (1.3M) | (3.1M) | (7.1M) | (6.6M) | (6.4M) |
| EBIT margin, % | -997.7% | -10.9% | -13.8% | -222.8% | -56518.1% | -4971.8% | |||
| Interest expense | 49.3K | 11.2K | 20.6K | 246.6K | 213.9K | 918.2K | 1.3M | 22.2M | |
| Pre tax profit | (552.2K) | (504.5K) | (1.1M) | (3.7M) | (13.2M) | (13.9M) | 15.6M | (12.9M) | |
| Income tax expense | 21.0K | 2.6K | |||||||
| Net Income | (2.0M) | (554.7K) | (504.5K) | (1.1M) | (3.7M) | (13.2M) | (13.9M) | 14.8M | (12.9M) |